{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:34:46Z","timestamp":1762954486886},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"959","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Gout is one of the best understood among the rheumatological disorders and one of the most satisfying to treat. Even non-specialists should be able to diagnose and treat most patients provided some important principles are appreciated. Management of a minority of patients, including those with renal impairment is difficult and often unsatisfactory, because of restricted treatment options. In this paper, the basic principles underlying the diagnosis and management of gout are discussed first, followed by practical approaches.<\/jats:p>","DOI":"10.1136\/pgmj.2004.030692","type":"journal-article","created":{"date-parts":[[2005,9,2]],"date-time":"2005-09-02T17:13:19Z","timestamp":1125681199000},"page":"572-579","source":"Crossref","is-referenced-by-count":42,"title":["Diagnosis and management of gout: a rational approach"],"prefix":"10.1093","volume":"81","author":[{"given":"E","family":"Suresh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,9,2]]},"reference":[{"key":"2023042408413122100_R1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/berh.2000.0087","article-title":"Gout and other crystal \u2013associated arthropathies.","volume":"14","author":"McGill","year":"2000","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"2023042408413122100_R2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricaemia. Risks and consequences in the normative aging study.","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"2023042408413122100_R3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/bmj.1.5851.449","article-title":"Effect of oestrogen therapy on plasma and urinary levels of uric acid.","author":"Nicholls","year":"1973","journal-title":"BMJ"},{"key":"2023042408413122100_R4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/art.10792","article-title":"Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output.","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/ard.51.3.375","article-title":"Genetic control of the renal clearance of urate: a study of twins.","volume":"51","author":"Emmerson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"2023042408413122100_R7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/rheumatology\/33.10.932","article-title":"Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling.","volume":"33","author":"Simmonds","year":"1994","journal-title":"Br J Rheumatol"},{"key":"2023042408413122100_R8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/rheumatology\/23.4.276","article-title":"Hyperuricaemia, gout and kidney function in New Zealand Maori men.","volume":"23","author":"Gibson","year":"1984","journal-title":"Br J Rheumatol"},{"key":"2023042408413122100_R9","first-page":"1350","article-title":"Gout, diet, and the insulin resistance syndrome.","volume":"29","author":"Fam","year":"2002","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0895-7061(96)00098-2","article-title":"Effect of insulin on renal sodium and uric acid handling in essential hypertension.","volume":"9","author":"Muscelli","year":"1996","journal-title":"Am J Hypertens"},{"key":"2023042408413122100_R11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/rheumatology\/keh019","article-title":"A (very) short history of diets for gout.","volume":"43","author":"Snaith","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"2023042408413122100_R12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0895-4356(94)00244-K","article-title":"The prevalence and prophylaxis of gout in England.","volume":"48","author":"Harris","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"2023042408413122100_R13","first-page":"1501","article-title":"The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.","volume":"27","author":"Lin","year":"2000","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C","article-title":"The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.","volume":"43","author":"Caspi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198908033210504","article-title":"Cyclosporine-induced hyperuricaemia and gout.","volume":"321","author":"Lin","year":"1989","journal-title":"N Engl J Med"},{"key":"2023042408413122100_R16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00861588","article-title":"Gout, uric acid and purine metabolism in paediatric nephrology.","volume":"7","author":"Cameron","year":"1993","journal-title":"Paediatr Nephrol"},{"key":"2023042408413122100_R17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0002-9149(99)00922-4","article-title":"Uric acid: Is it a risk factor for cardiovascular disease?","volume":"85","author":"Rich","year":"2000","journal-title":"Am J Cardiol"},{"key":"2023042408413122100_R18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.berh.2004.01.001","article-title":"Primary prevention in rheumatology: the importance of hyperuricaemia.","volume":"18","author":"Vazquez-Mellado","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2023042408413122100_R19","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle aged men: a prospective cohort study.","volume":"164","author":"Niskanen","year":"2004","journal-title":"Arch Intern Med"},{"key":"2023042408413122100_R20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.HYP.34.1.144","article-title":"Serum uric acid and cardiovascular events in successfully treated hypertensive patients.","volume":"34","author":"Alderman","year":"1999","journal-title":"Hypertension"},{"key":"2023042408413122100_R21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.STR.29.3.635","article-title":"Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus.","volume":"29","author":"Lehto","year":"1998","journal-title":"Stroke"},{"key":"2023042408413122100_R22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death. The Framingham heart study.","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann Intern Med"},{"key":"2023042408413122100_R23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/hrt.78.2.147","article-title":"Serum urate and the risk of major coronary heart disease events.","volume":"78","author":"Wannamethee","year":"1997","journal-title":"Heart"},{"key":"2023042408413122100_R24","first-page":"975","article-title":"Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona young men atherosclerosis risk factors study.","volume":"20","author":"Bonora","year":"1996","journal-title":"Int J Obes Relat Metabol Disord"},{"key":"2023042408413122100_R25","first-page":"677","article-title":"Serum uric acid and hypertension: The Olivetti heart study.","volume":"8","author":"Jossa","year":"1994","journal-title":"J Hum Hypertens"},{"key":"2023042408413122100_R26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9150(03)00093-5","article-title":"Serum uric acid in hypertensive patients with and without peripheral arterial disease.","volume":"168","author":"Langlois","year":"2003","journal-title":"Atherosclerosis"},{"key":"2023042408413122100_R27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/ard.57.9.509","article-title":"Hyperlipidaemia in hyperuricaemia and gout.","volume":"57","author":"Emmerson","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"2023042408413122100_R28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1047-2797(97)00204-4","article-title":"Relations of hyperuricaemia with various components of the insulin resistance syndrome in young black and white adults: The CARDIA study. Coronary artery risk development in young adults.","volume":"8","author":"Rathmann","year":"1998","journal-title":"Ann Epidemiol"},{"key":"2023042408413122100_R29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0026-0495(99)90163-4","article-title":"Serum leptin is associated with serum uric acid concentrations in humans.","volume":"48","author":"Fruehwald-Schultes","year":"1999","journal-title":"Metabolism"},{"key":"2023042408413122100_R30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/ard.33.4.313","article-title":"Factors affecting urate solubility in vitro.","volume":"33","author":"Kippen","year":"1974","journal-title":"Ann Rheum Dis"},{"key":"2023042408413122100_R31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7326\/0003-4819-86-2-230","article-title":"The pathogenesis of podagra.","volume":"86","author":"Simkin","year":"1977","journal-title":"Ann Intern Med"},{"key":"2023042408413122100_R32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.17.4.388","article-title":"Osteoarthrosis and disc degeneration in an urban population.","volume":"17","author":"Kellgren","year":"1958","journal-title":"Ann Rheum Dis"},{"key":"2023042408413122100_R33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1780150209","article-title":"The influence of temperature on the solubility of monosodium urate.","volume":"15","author":"Loeb","year":"1972","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0046-8177(73)80013-9","article-title":"The synovitis of acute gouty arthritis. A light and electron microscopic study.","volume":"4","author":"Agudelo","year":"1973","journal-title":"Hum Pathol"},{"key":"2023042408413122100_R35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(62)90501-9","article-title":"Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals.","volume":"ii","author":"Faires","year":"1962","journal-title":"Lancet"},{"key":"2023042408413122100_R36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-91-1-56","article-title":"Urate crystals in asymptomatic metatarsophalangeal joints.","volume":"91","author":"Weinberger","year":"1979","journal-title":"Ann Intern Med"},{"key":"2023042408413122100_R37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout.","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann Intern Med"},{"key":"2023042408413122100_R38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/art.1780340203","article-title":"Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.","volume":"34","author":"Pascual","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R39","article-title":"The pathogenesis of gout","volume-title":"Rheumatology","author":"McLean","year":"2003","edition":"3rd"},{"key":"2023042408413122100_R40","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.10326","article-title":"Monosodium urate monohydrate crystal induced inflammation in vivo: quantitative histomorphometric analysis of cellular events.","volume":"46","author":"Schiltz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.1941.02820060001001","article-title":"Diagnosis and treatment of gout and gouty arthritis.","volume":"116","author":"Hench","year":"1941","journal-title":"JAMA"},{"key":"2023042408413122100_R42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0002-9343(74)90639-1","article-title":"Acute polyarticular gout.","volume":"56","author":"Hadler","year":"1974","journal-title":"Am J Med"},{"key":"2023042408413122100_R43","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/art.1780080509","article-title":"Hyperuricaemia, acute gout, renal insufficiency and urate nephrolithiasis due to starvation.","volume":"8","author":"Drenick","year":"1965","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R44","first-page":"849","article-title":"Acute gout precipitated by total parenteral nutrition.","volume":"30","author":"Moyer","year":"2003","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/rheumatology\/keg297","article-title":"Concomitant septic and gouty arthritis- an analysis of 30 cases.","volume":"42","author":"Yu","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"2023042408413122100_R46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0049-0172(96)80038-2","article-title":"Magnetic resonance imaging of tophaceous gout in the hands and wrists.","volume":"25","author":"Popp","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"2023042408413122100_R47","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1001\/archinte.1988.00380080102027","article-title":"Tophaceous deposits in the fingerpads without gouty arthritis.","volume":"148","author":"Schmerling","year":"1988","journal-title":"Arch Intern Med"},{"key":"2023042408413122100_R48","first-page":"1950","article-title":"The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis.","volume":"29","author":"Urano","year":"2002","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R49","first-page":"974","article-title":"The acute phase response in gout.","volume":"14","author":"Roseff","year":"1987","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R50","first-page":"388","article-title":"Gram staining in the diagnosis of acute septic arthritis.","volume":"68","author":"Faraj","year":"2002","journal-title":"Acta Orthop Belg"},{"key":"2023042408413122100_R51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.1985.tb05110.x","article-title":"Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.","volume":"20","author":"Butler","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"2023042408413122100_R52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(86)90131-2","article-title":"Flurbiprofen in the treatment of acute gout. A comparison with indomethacin.","volume":"80","author":"Lomen","year":"1986","journal-title":"Am J Med"},{"key":"2023042408413122100_R53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1185\/03007999109111513","article-title":"Effectiveness of etodolac (Lodine) compared with naproxen in patients with acute gout.","volume":"12","author":"Maccagno","year":"1991","journal-title":"Curr Med Res Opin"},{"key":"2023042408413122100_R54","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.","volume":"324","author":"Schumacher HR Jr, Boice","year":"2002","journal-title":"BMJ"},{"key":"2023042408413122100_R55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0149-2918(04)90035-5","article-title":"A single-blind, randomised, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium and meloxicam in patients with acute gouty arthritis.","volume":"26","author":"Cheng","year":"2004","journal-title":"Clin Ther"},{"key":"2023042408413122100_R56","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(04)17514-4","article-title":"Risk of cardiovascular events and rofecoxib: cumulative meta-analysis.","volume":"364","author":"Juni","year":"2004","journal-title":"Lancet"},{"key":"2023042408413122100_R57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199602153340707","article-title":"The management of gout.","volume":"334","author":"Emmerson","year":"1996","journal-title":"N Engl J Med"},{"key":"2023042408413122100_R58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2125.1987.tb03132.x","article-title":"Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs.","volume":"24","author":"Bellamy","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"2023042408413122100_R59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout.","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"2023042408413122100_R60","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI109523","article-title":"Mechanism of action of colchicine in acute urate crystal-induced arthritis.","volume":"64","author":"Spilberg","year":"1979","journal-title":"J Clin Invest"},{"key":"2023042408413122100_R61","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199606063342313","article-title":"Management of gout.","volume":"334","author":"Sarkozi","year":"1996","journal-title":"N Engl J Med"},{"key":"2023042408413122100_R62","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bmj.327.7426.1275","article-title":"Colchicine in acute gout.","volume":"327","author":"Morris","year":"2003","journal-title":"BMJ"},{"key":"2023042408413122100_R63","first-page":"2285","article-title":"Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide.","volume":"26","author":"Fernandez","year":"1999","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-0172(90)90070-V","article-title":"Systemic steroid therapy for acute gout: a clinical trial and review of the literature.","volume":"19","author":"Groff","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"2023042408413122100_R65","first-page":"1325","article-title":"Comparison of adrenocorticotrophic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis.","volume":"21","author":"Siegel","year":"1994","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R66","first-page":"111","article-title":"Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gout.","volume":"20","author":"Alloway","year":"1993","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R67","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1681\/ASN.V115974","article-title":"Renal transplant-associated hyperuricaemia and gout.","volume":"11","author":"Clive","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2023042408413122100_R68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(98)00323-4","article-title":"Effective management of gout: an analogy.","volume":"105","author":"Wortmann","year":"1998","journal-title":"Am J Med"},{"key":"2023042408413122100_R69","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men.","volume":"350","author":"Choi","year":"2004","journal-title":"N Engl J Med"},{"key":"2023042408413122100_R70","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/ard.59.7.539","article-title":"Beneficial effects of weight loss associated with moderate calorie\/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study.","volume":"59","author":"Dessein","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"2023042408413122100_R71","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: a prospective study.","volume":"363","author":"Choi","year":"2004","journal-title":"Lancet"},{"key":"2023042408413122100_R72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-55-2-179","article-title":"Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects.","volume":"55","author":"Yu","year":"1961","journal-title":"Ann Intern Med"},{"key":"2023042408413122100_R73","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.7326\/0003-4819-67-6-1133","article-title":"Uric acid nephrolithiasis in gout: Predisposing factors.","volume":"67","author":"Yu","year":"1967","journal-title":"Ann Intern Med"},{"key":"2023042408413122100_R74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/art.20405","article-title":"A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy.","volume":"51","author":"Shoji","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R75","first-page":"1575","article-title":"Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.","volume":"31","author":"Riedel","year":"2004","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R76","first-page":"1246","article-title":"Intermittent control of hyperuricaemia in the treatment of gout.","volume":"16","author":"Bull","year":"1989","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R77","first-page":"1383","article-title":"Withdrawal of long-term anti-hyperuricemic therapy in tophaceous gout.","volume":"20","author":"Van Lieshout- Zuidema","year":"1993","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency.","volume":"76","author":"Hande","year":"1984","journal-title":"Am J Med"},{"key":"2023042408413122100_R79","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5694\/j.1326-5377.1993.tb137784.x","volume":"159","author":"Kot","year":"1993","journal-title":"Med J Aust"},{"key":"2023042408413122100_R80","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","article-title":"Colchicine myopathy and neuropathy.","volume":"316","author":"Kuncl","year":"1987","journal-title":"N Engl J Med"},{"key":"2023042408413122100_R81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.40.3.245","article-title":"Acute adverse reactions attributed to allopurinol in hospitalised patients.","volume":"40","author":"McInnes","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"2023042408413122100_R82","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.1974.00320210163026","article-title":"Severe allopurinol hypersensitivity. Association with thiazides and prior renal compliance.","volume":"134","author":"Young JL Jr, Boswell","year":"1974","journal-title":"Arch Intern Med"},{"key":"2023042408413122100_R83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.1990.tb00195.x","article-title":"Azathioprine and allopurinol: a potentially dangerous combination.","volume":"228","author":"Venkat Raman","year":"1990","journal-title":"J Intern Med"},{"key":"2023042408413122100_R84","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(92)90236-5","article-title":"Desensitisation to allopurinol in patients with gout and cutaneous reactions.","volume":"93","author":"Fam","year":"1992","journal-title":"Am J Med"},{"key":"2023042408413122100_R85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7","article-title":"Efficacy and safety of desensitization to allopurinol following cutaneous reactions.","volume":"44","author":"Fam","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R86","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/0140-6736(91)93141-U","article-title":"Identification of the causes of persistent hyperuricaemia.","volume":"337","author":"Emmerson","year":"1991","journal-title":"Lancet"},{"key":"2023042408413122100_R87","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/9.5.548","article-title":"Excellent uricosuric efficacy of benzbromarone in cyclosporine-A-treated renal transplant patients: a prospective study.","volume":"9","author":"Zurcher","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"2023042408413122100_R88","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1440-1746.2002.02692.x","article-title":"Fulminant hepatic failure associated with benzbromarone treatment: a case report.","volume":"17","author":"Arai","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"2023042408413122100_R89","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate lowering therapy on the velocity of size reduction of tophi in chronic gout.","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R90","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/ard.62.6.572","article-title":"Effects of combination treatment using anti-hyperuricemic agents with fenofibrate and\/or losartan on uric acid metabolism.","volume":"62","author":"Takahashi","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2023042408413122100_R91","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10067-002-0658-1","article-title":"Long-term remission from gout associated with fenofibrate therapy.","volume":"22","author":"Hepburn","year":"2003","journal-title":"Clin Rheumatol"},{"key":"2023042408413122100_R92","first-page":"S142","article-title":"Phase II, dose response, safety and efficacy clinical trial of a new oral xanthine oxidase inhibitor TMX-67 (febuxostat) in subjects with gout.","volume":"46","author":"Joseph-Ridge","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2023042408413122100_R93","first-page":"S530","article-title":"Safety, tolerability, pharmacokinetics, and lowering uric acid effect of repeated daily dosing with Y-700, a novel xanthine oxidase inhibitor.","volume":"48","author":"Noma","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2023042408413122100_R94","first-page":"1942","article-title":"Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and pre-clinical studies.","volume":"29","author":"Bomalaski","year":"2002","journal-title":"J Rheumatol"},{"key":"2023042408413122100_R95","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/art.20438","article-title":"Gout: On the brink of novel therapeutic options for an ancient disease.","volume":"50","author":"Bieber","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/81\/959\/572\/50026053\/postgradmedj-81-572.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/81\/959\/572\/50026053\/postgradmedj-81-572.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:50:17Z","timestamp":1682326217000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/81\/959\/572\/7032251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":95,"journal-issue":{"issue":"959","published-online":{"date-parts":[[2005,9,2]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2004.030692","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,9,1]]}}}